Gujarat Themis Biosyn’s Promoter is planning to offload 9.79% (14,23,000 equity shares) of its shareholding in the Company to comply with the minimum public shareholding (MPS) requirements as prescribed by Securities and Exchange Board of India (SEBI).
Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company, having plants at Vapi, Hyderabad, with group turnover of over $40 million. The company has world-wide exports to satisfied customers, having customised facility for all products.